August 17, 2017 5:35 PM ET


Company Overview of Kanisa Pharmaceuticals, Inc.

Kanisa Pharmaceuticals, Inc. INSIDERS ON Board Members

Name (Connections)RelationshipsTitleAge
Scott Glenn 25 RelationshipsChairman, Chief Executive Officer and President67
Branimir Sikic M D 11 RelationshipsChief Scientific Officer and Member of Scientific Advisory Board--

Other Board Members on Board Members

Name (Connections)RelationshipsType of Board MembersPrimary CompanyAge
Manish Chapekar 11 RelationshipsMember of the Board of DirectorsKanisa Pharmaceuticals, Inc.--
Michael Walsh 18 RelationshipsMember of the Board of DirectorsWindamere Venture Partners, LLC57
George Sledge Jr., M.D.120 RelationshipsMember of Advisory BoardSyndax Pharmaceuticals, Inc.65
Charles Schiffer M.D.22 RelationshipsMember of Advisory BoardKanisa Pharmaceuticals, Inc.--
Arnold Oronsky Ph.D.139 RelationshipsMember of the Board of DirectorsInterWest Partners LLC78
Alan List M.D.48 RelationshipsMember of Advisory BoardCellular Biomedicine Group Inc.--
Daniel Hoth M.D.57 RelationshipsMember of Advisory BoardSemafore Pharmaceuticals, Inc.71
Sigrid Van Bladel Ph.D.44 RelationshipsMember of the Board of DirectorsAberdare Ventures51
Frederick Appelbaum M.D., Ph.D.49 RelationshipsMember of Advisory BoardSeattle Cancer Care Alliance--
Michael Johnson 19 RelationshipsMember of the Board of DirectorsEli Lilly Federal Credit Union--

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Connected People on the Kanisa Pharmaceuticals, Inc. Board

Arnold L. Oronsky Ph.D.139 Relationships
George W. Sledge Jr., M.D.120 Relationships
Daniel F. Hoth M.D.57 Relationships
Frederick R. Appelbaum M.D., Ph.D.49 Relationships
Alan F. List M.D.48 Relationships

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kanisa Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at